Archives:
Welcome to the 2022 Pipeline Report. Our annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
You can now read the 2022 Pipeline Report updates online, via easily downloadable PDFs, and we’ll be adding more in the coming months. Please feel free to use and share this resource widely in your scientific, policy, and advocacy work.
HCV
Long-Acting Technologies Trials Tracker for Hep C, Opioid Use and Overdose Prevention Therapy, and Malaria
By Joelle Dountio Ofimboudem
July 2022
July 2022
HIV
Antiretroviral Therapy
By Richard Jefferys
July 2022
HIV Vaccines and Passive Immunization
By Richard Jefferys
July 2022
PrEP and Microbicides
By Richard Jefferys
July 2022
Research Toward a Cure and Immune-Based Therapies
By Richard Jefferys
July 2022
July 2022
HIV Vaccines and Passive Immunization
July 2022
PrEP and Microbicides
July 2022
Research Toward a Cure and Immune-Based Therapies
July 2022
TB
TB Treatment
By Lindsay McKenna
December 2022
Tuberculosis Diagnostics
By David Branigan
November 2022
Tuberculosis Vaccines
By Mike Frick
October 2022
December 2022
Tuberculosis Diagnostics
November 2022
Tuberculosis Vaccines
October 2022